134 related articles for article (PubMed ID: 688282)
1. Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine, and medroxyprogesterone acetate.
Katakkar SB; Franks CR
Cancer Treat Rep; 1978 Sep; 62(9):1379-80. PubMed ID: 688282
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
[TBL] [Abstract][Full Text] [Related]
3. Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.
Samuels BL; Hollis DR; Rosner GL; Trump DL; Shapiro CL; Vogelzang NJ; Schilsky RL
Clin Cancer Res; 1997 Nov; 3(11):1977-84. PubMed ID: 9815587
[TBL] [Abstract][Full Text] [Related]
4. Advanced adenocarcinoma of the kidney: therapy with lomustine, vinblastine, hydroxyurea, and medroxyprogesterone acetate and regression analysis of factors relating to survival.
Brubaker LH; Troner MB; Birch R
Cancer Treat Rep; 1983; 67(7-8):741-2. PubMed ID: 6223695
[No Abstract] [Full Text] [Related]
5. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
Kjaer M; Frederiksen PL
Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
[No Abstract] [Full Text] [Related]
6. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
[No Abstract] [Full Text] [Related]
7. High-dose methotrexate with leucovorin rescue, vinblastine, and bleomycin with or without tamoxifen in metastatic renal cell carcinoma.
Bell DR; Aroney RS; Fisher RJ; Levi JA
Cancer Treat Rep; 1984 Apr; 68(4):587-90. PubMed ID: 6201268
[TBL] [Abstract][Full Text] [Related]
8. [Therapy of renal cell carcinoma. 1. Hormonal therapy].
Kobayashi M; Imai K; Nakai K; Suzuki T; Nagata M; Ito Y; Yamanaka H
Hinyokika Kiyo; 1985 Sep; 31(9):1531-7. PubMed ID: 2417463
[TBL] [Abstract][Full Text] [Related]
9. Randomized phase II study comparing thalidomide with medroxyprogesterone acetate in patients with metastatic renal cell carcinoma.
Lee CP; Patel PM; Selby PJ; Hancock BW; Mak I; Pyle L; James MG; Beirne DA; Steeds S; A'Hern R; Gore ME; Eisen T
J Clin Oncol; 2006 Feb; 24(6):898-903. PubMed ID: 16484699
[TBL] [Abstract][Full Text] [Related]
10. [Pulmonary metastasis of renal cell carcinoma].
Satomi Y
Gan No Rinsho; 1983 May; 29(6):555-60. PubMed ID: 6876423
[TBL] [Abstract][Full Text] [Related]
11. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
13. [Chemo-(hormonal)-therapy of advanced ovarian neoplasms in FIGO stages III and IV. Prospective SAKK-study 20/71].
Senn HJ; Lei D; Castaño-Almendral A; Brunner KW; Martz G; Obrecht P; Melchert F; Rhomberg W
Schweiz Med Wochenschr; 1980 Aug; 110(33):1202-8. PubMed ID: 7423163
[TBL] [Abstract][Full Text] [Related]
14. [the oral use of a progestational hormone (Provera 100) as an adjuvant in therapy of adenocarcinoma of the kidney. Preliminary report].
Liberti M; Di Silverio F; Concolino G; Tenaglia R; Marocchi A
Minerva Urol; 1980; 32(3):175-8. PubMed ID: 7432332
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
[TBL] [Abstract][Full Text] [Related]
16. Vinblastine and estramustine phosphate in metastatic renal cell carcinoma: a phase II trial of the Fox Chase Network.
Haas NB; Giantonio BJ; Litwin S; Minniti CJ; Fox S; Yeslow G; Reilly R; Nahum K; Greenberg R; Halbherr T; Hudes GR
Cancer; 2003 Nov; 98(9):1837-41. PubMed ID: 14584064
[TBL] [Abstract][Full Text] [Related]
17. Combination chemoimmunotherapy for advanced renal carcinoma with Adriamycin, bleomycin, vincristine, cyclophosphamide, plus BCG.
Dana BW; Alberts DS
Cancer Clin Trials; 1981; 4(2):205-7. PubMed ID: 6166407
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
19. Metastatic renal cell carcinoma arising in a congenital solitary kidney. Treatment with interferon-containing combinations. A case report and a review of the literature.
Merimsky O; Laufer R; Chaitchik S
J Urol (Paris); 1989; 95(4):243-5. PubMed ID: 2529317
[TBL] [Abstract][Full Text] [Related]
20. Treatment of renal carcinoma: a phase III randomized trial of oral medroxyprogesterone (Provera), hydroxyurea, and nafoxidine.
Stolbach LL; Begg CB; Hall T; Horton J
Cancer Treat Rep; 1981; 65(7-8):689-92. PubMed ID: 6454485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
